Total Payments
$592.90
2024 Payments
$35.38
Companies
10
Transactions
15
Medicare Patients
2,940
Medicare Billing
$500,027
Payment Breakdown by Category
Food & Beverage$592.90 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $592.90 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $226.86 | 2 | $0 (2018) |
| La Jolla Pharmaceutical Company | $122.39 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $60.80 | 3 | $0 (2018) |
| DEXCOM, INC. | $52.87 | 1 | $0 (2021) |
| ABBVIE INC. | $35.38 | 2 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $27.63 | 2 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $24.57 | 1 | $0 (2019) |
| PFIZER INC. | $15.31 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $14.64 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12.45 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35.38 | 2 | ABBVIE INC. ($35.38) |
| 2023 | $122.39 | 1 | La Jolla Pharmaceutical Company ($122.39) |
| 2021 | $67.51 | 2 | DEXCOM, INC. ($52.87) |
| 2020 | $13.09 | 1 | Actelion Pharmaceuticals US, Inc. ($13.09) |
| 2019 | $39.11 | 2 | Novartis Pharmaceuticals Corporation ($24.57) |
| 2018 | $256.95 | 4 | Amgen Inc. ($226.86) |
| 2017 | $58.47 | 3 | Otsuka America Pharmaceutical, Inc. ($43.16) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/07/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/28/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $122.39 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 10/20/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $52.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/04/2020 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Cardiology | ||||||
| 07/30/2019 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Cardiology | ||||||
| 01/10/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/02/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: RESPIRATORY | ||||||
| 04/12/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 03/27/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $101.86 | General |
| Category: Cardiology | ||||||
| 02/27/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: NEPHROLOGY | ||||||
| 12/14/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: NEPHROLOGY | ||||||
| 10/23/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/25/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 612 | 935 | $399,578 | $89,930 |
| 2022 | 3 | 759 | 817 | $582,444 | $132,844 |
| 2021 | 6 | 866 | 912 | $590,878 | $152,257 |
| 2020 | 8 | 703 | 784 | $489,466 | $124,996 |
Total Patients
2,940
Total Services
3,448
Medicare Billing
$500,027
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 253 | 257 | $188,721 | $35,870 | 19.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 165 | 422 | $111,960 | $28,544 | 25.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 136 | 140 | $54,800 | $13,717 | 25.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 58 | 116 | $44,097 | $11,798 | 26.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 482 | 523 | $382,555 | $87,548 | 22.9% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 235 | 250 | $167,945 | $37,388 | 22.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 42 | 44 | $31,944 | $7,908 | 24.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 512 | 541 | $360,574 | $94,138 | 26.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 260 | 273 | $167,076 | $43,117 | 25.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 44 | 44 | $35,292 | $8,087 | 22.9% |
| 99236 | Hospital observation or inpatient care high severity, 55 minutes per day | Facility | 2021 | 21 | 21 | $15,057 | $3,911 | 26.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 18 | $6,174 | $1,640 | 26.6% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 15 | 15 | $6,705 | $1,364 | 20.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 392 | 409 | $280,662 | $72,717 | 25.9% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 105 | 112 | $69,996 | $18,030 | 25.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 62 | 71 | $64,040 | $14,201 | 22.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 24 | 71 | $24,287 | $6,562 | 27.0% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 51 | 51 | $22,797 | $6,072 | 26.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 33 | 33 | $14,846 | $3,903 | 26.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 18 | 18 | $6,429 | $1,787 | 27.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 18 | 19 | $6,409 | $1,725 | 26.9% |
About Dr. Imran Khan, MD
Dr. Imran Khan, MD is a Hospitalist healthcare provider based in Stratford, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2009. The National Provider Identifier (NPI) number assigned to this provider is 1184852626.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Imran Khan, MD has received a total of $592.90 in payments from pharmaceutical and medical device companies, with $35.38 received in 2024. These payments were reported across 15 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($592.90).
As a Medicare-enrolled provider, Khan has provided services to 2,940 Medicare beneficiaries, totaling 3,448 services with total Medicare billing of $500,027. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine, Hospitalist
- Location Stratford, NJ
- Active Since 06/23/2009
- Last Updated 07/19/2013
- Taxonomy Code 208M00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184852626
Products in Payments
- Repatha (Biological) $226.86
- GIAPREZA (Drug) $122.39
- SAMSCA (Drug) $60.80
- DEXCOM G6 TRANSMITTER (Device) $52.87
- OPSUMIT (Drug) $27.63
- ENTRESTO (Drug) $24.57
- TEFLARO (Drug) $17.71
- DALVANCE (Drug) $17.67
- ELIQUIS (Drug) $15.31
- XARELTO (Drug) $14.64
- SPIRIVA RESPIMAT (Drug) $12.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.